Cargando…
Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial
BACKGROUND: Bipolar disorder is a lifelong episodic condition characterized by mood swings between mania and depression. Several lines of evidence suggest that serotonin is likely to play a pivotal role in the pathophysiology of bipolar disorder. Ritanserin, a 5-HT(2 )receptor antagonist, has been r...
Autores principales: | Akhondzadeh, Shahin, Mohajari, Hassan, Mohammadi, Mohammad Reza, Amini, Homayoun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194858/ https://www.ncbi.nlm.nih.gov/pubmed/12816549 http://dx.doi.org/10.1186/1471-244X-3-7 |
Ejemplares similares
-
The efficacy of vitamin B6 as an adjunctive therapy to lithium in improving the symptoms of acute mania in patients with bipolar disorder, type 1; a double‐blind, randomized, placebo‐controlled, clinical trial
por: Badrfam, Rahim, et al.
Publicado: (2021) -
Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania
por: Ostacher, Michael J, et al.
Publicado: (2015) -
A COMPARATIVE STUDY OF SIDE-EFFECTS OF LITHIUM, CARBAMAZEPINE AND HALOPERIDOL IN ACUTE MANIA
por: Trivedi, J.K., et al.
Publicado: (1996) -
Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]
por: Akhondzadeh, Shahin, et al.
Publicado: (2004) -
Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)